Please use this identifier to cite or link to this item:
Title: Current practices in the management of lymphatic filariasis ( Review )
Authors: Bockarie, M.J.
Taylor, M.J.
Gyapong, J.O.
Keywords: Albendazole; Diethylcarbamazine; Doxycycline; Ivermectin; Lymphatic filariasis; Mass drug administration; Morbidity control; Neglected tropical disease; Preventive chemotherapy; Vector control; Wolbachia
Issue Date: Jun-2009
Citation: Bockarie, M. J., Taylor, M. J., & Gyapong, J. O. (2009). Current practices in the management of lymphatic filariasis. Expert Review of Anti-Infective Therapy, 7(5), 595-605.
Abstract: Lymphatic filariasis is a major cause of acute and chronic morbidity in 81 countries. The availability of safe treatment regimens along with rapid diagnostic tools resulted in a global program to eliminate the disease. The two main objectives of the global elimination program are to interrupt transmission of the parasites and to provide care for those with the disease. The strategy for transmission interruption is preventive chemotherapy through mass drug administration. This article reviews the current treatment regimens for lymphatic filariasis and discusses the challenges posed by co-endemicity with other diseases. The role of integrated vector management as a supplementary strategy for mass drug administration and new strategies for treatment and morbidity control through antibiotic targeting of the Wolbachia endosymbionts are also discussed.
ISSN: 14787210
Appears in Collections:School of Public Health 9

Files in This Item:
There are no files associated with this item.

Items in UGSpace are protected by copyright, with all rights reserved, unless otherwise indicated.